You are here
Lactoferrin in Primate and Mouse Models of Asthma
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AI058553-01
Agency Tracking Number: AI058553
Amount:
$99,925.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
AGENNIX, INC.
8 GREENWAY PLZ, STE 910
HOUSTON, TX
77046
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: ATUL Varadhachary
Phone: (713) 552-1091
Email: AVARADHACHARY@AGENNIX.COM
Phone: (713) 552-1091
Email: AVARADHACHARY@AGENNIX.COM
Business Contact
Name: RICK BARSKY
Phone: (713) 552-1091
Email: RBARSKY@AGENNIX.COM
Phone: (713) 552-1091
Email: RBARSKY@AGENNIX.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The purpose of this research is to extend work to determine the efficacy of orally administered recombinant human lactoferrin (rhLF) in an established primate model of asthma. Asthma is one of the most prevalent chr
* Information listed above is at the time of submission. *
